2024-12-23 07:01:30
Author: Croma-Pharma / 2023-07-22 21:01 / Source: Croma-Pharma

Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators

Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators

VIENNA,March 30,2023 -- Croma (Croma-Pharma® GmbH) is a global player and challenger in the dynamically growing,minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt,a complete series of injectable skin boosters,Croma is now further broadening its already comprehensive portfolio. Skin boosters are an important pillar of a minimally invasive aesthetics portfolio,next to HA fillers,botulinum toxin and PDO threads,allowing for combination therapies and a full-face approach. Read More

Contact:


Uschi Mayer


External Communications & PR


CROMA-PHARMA GmbH


Cromazeile 2,A-2100 Leobendorf,Austria


M.: +43 676 84 68 68966


E: uschi.mayer@croma.at

Logo:http://cusmail.com/res/2023/07-22/21/667fbd9e7e97e1cea0be2a8814af00d0.jpg

Tags: Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

Previous:

Next:

Leave a comment

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release